News

News

VAIM GLOBAL Expands Global Presence with Participation in IMCAS 2025

Author
Ju******************
Date
2025-02-28 14:47
Views
71


VAIM GLOBAL Expands Global Presence with Participation in IMCAS 2025

VAIM GLOBAL held a symposium introducing "JUVELOOK" and "LENISNA" at the world's largest aesthetic and plastic surgery conference, "IMCAS 2025" (hereinafter referred to as IMCAS), which took place from January 30 to February 2 (local time) at the Palais des Congrès de Paris in France.

Since 2022, VAIM GLOBAL has participated in IMCAS for four consecutive years, and this year, the company hosted an exclusive symposium at the event. The company presented research on LENISNA's subcutaneous fat layer injection, demonstrating its effectiveness in increasing subcutaneous fat tissue volume, and shared various treatment techniques utilizing JUVELOOK. Additionally, during the event, VAIM GLOBAL strengthened its global network through opening booth and meetings with overseas distributors and corporate representatives. These meetings facilitated the discovery of new business partners and expanded promotional efforts in untapped markets.

A representative from VAIM GLOBAL said, "We will continue to participate in global academic conferences to further enhance our brand recognition."

Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM Global, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM Global currently has product export contracts with 72 countries.